Patients undergoing craniotomy with general anesthesia.
Conditions
Interventions
Intervention 1: Intervention group: Ropivacaine 0.5%, 1 ml in incision place (before incision), local infiltration. Intervention 2: Control group: normal salin solusion
1 ml in incision place (before incision), local infiltration.
Placebo
Intervention group: Ropivacaine 0.5%, 1 ml in incision place (before incision), local infiltration
Control group: normal salin solusion
1 ml in incision place (before incision), local infiltration
Sponsors
Lorestan University of Medical Sciences (Assistance of research & technology)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: absence of underlying renal, hepatic, and consent to participate in the study. Exclusion criteria: not thrilled inclusion criteria and having a history of drug allergy .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vital sign(The systolic, diastolic and mean arterial blood pressure and heart rate). Timepoint: vital sign(The systolic, diastolic and mean arterial blood pressure and heart rate):after intubation and 7-10 min after intubation and 30 second and 1,3,5,10 min after incision. Method of measurement: The systolic, diastolic and mean arterial blood pressure:mmHg,monitoring.Heart Rate:frequency.monitoring.;Narcotic drug. Timepoint: the end of surgery. Method of measurement: gram.;Isoflorane gas. Timepoint: the end of surgery. Method of measurement: %. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Siavash Beiranvand
Lorestan University of Medical Sciences
Outcome results
None listed